Compare Pharmadrug (G11) vs. Competitors
0 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| DE:G11Pharmadrug | EUR 0.01 | EUR 426.89K | -0.93 | -30.00% | ― | Unlock the DE:G11 analyst price target with TipRanks Premium | DE:G11 | Unlock the DE:G11 top-analyst price target with TipRanks Premium | ||
| TSE:RVVRevive Therapeutics | CAD 0.02 | CAD 8.89M | -12.50 | 100.00% | ― | Unlock the TSE:RVV analyst price target with TipRanks Premium | DE:G11 vs TSE:RVV | Unlock the TSE:RVV top-analyst price target with TipRanks Premium | ||
| TSE:INNOInnoCan Pharma | CAD 1.90 | CAD 8.55M | -6.25 | -89.44% | ― | Unlock the TSE:INNO analyst price target with TipRanks Premium | DE:G11 vs TSE:INNO | Unlock the TSE:INNO top-analyst price target with TipRanks Premium | ||
| TSE:RAMMRamm Pharma | CAD 0.01 | CAD 596.95K | -0.07 | -33.33% | ― | Unlock the TSE:RAMM analyst price target with TipRanks Premium | DE:G11 vs TSE:RAMM | Unlock the TSE:RAMM top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| DE:G11 | Pharmadrug | 0.01 | -0.00 | -12.50% | |
| TSE:RVV | Revive Therapeutics | 0.02 | 0.01 | 33.33% | |
| TSE:INNO | InnoCan Pharma | 1.90 | -15.62 | -89.16% | |
| TSE:RAMM | Ramm Pharma | 0.01 | -0.01 | -50.00% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
